XTX Topco’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$389K Buy
+128,088
New +$383K 0.01% 2681
2024
Q3
Sell
-14,378
Closed -$95.6K 2048
2024
Q2
$95.6K Buy
+14,378
New +$106K 0.01% 1424
2023
Q4
Sell
-204,998
Closed -$533K 1545
2023
Q3
$533K Buy
+204,998
New +$588K 0.09% 360
2023
Q2
Sell
-21,271
Closed -$89.8K 1380
2023
Q1
$89.8K Buy
+21,271
New +$253K 0.02% 1112
2022
Q2
Sell
-19,665
Closed -$120K 829
2022
Q1
$120K Buy
19,665
+4,898
+33% +$36.1K 0.05% 485
2021
Q4
$135K Buy
+14,767
New +$157K 0.08% 419

Other funds holding ALT

XTX Topco's ALT Position: Q2 2026 in Review

XTX Topco opened a new position in Altimmune (ALT) in Q2 2026: 128,088 shares worth $389K. The stake represents 0.01% of the portfolio and ranks #2681 among its holdings. This is a return to the name: XTX Topco previously reported a position in ALT as recently as Q2 2024.

XTX Topco first reported a position in ALT in Q4 2021 and has held it in 6 quarters since. The position peaked at $533K in Q3 2023. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • XTX Topco held 128,088 shares of Altimmune worth $389K as of Q2 2026.
  • Altimmune was a new XTX Topco position in Q2 2026.
  • Altimmune made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2681 holding.
  • XTX Topco first reported a position in Altimmune in Q4 2021 and has held it in 6 quarters since.
  • XTX Topco's Altimmune position peaked at $533K in Q3 2023.
  • 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.